BioVector® TK-1B 小鼠T淋巴细胞瘤细胞系 / BioVector® TK-1B Mouse T-Cell Lymphoma Cell Line

背景与来源说明 / Context & Provenance: BioVector® TK-1B 是一种在免疫学和毒理学遗传学研究中应用极为广泛的经典恶性小鼠 T 淋巴细胞系统体外模型。该细胞系最初由科学家从 AKR/J 纯系小鼠自发生成的 T 细胞淋巴瘤（T-cell Lymphoma）组织中分离并永生化建立。作为检测基因突变、DNA 损伤和细胞毒性的黄金标准细胞之一，它被广泛收录于全球核心细胞保藏中心（包括 DSMZ、ATCC 和欧洲 ECACC）。本技术档案严格基于官方保藏库的特征性鉴定参数进行双语编制。

通用定义BioVector® TK-1B 是一种源自小鼠（Mus musculus）的胸苷激酶缺陷型（Thymidine Kinase Deficient, $TK^{-/-}或TK1^{-/-}）恶性 T 淋巴细胞悬浮生长型细胞系。

该细胞系在分子遗传学和药物毒理学中占有举足轻重的地位。其最核心的特征是通过特定的基因选育或化学诱变，使其两份染色体上的胸苷激酶-1（Thymidine Kinase 1, $Tk1$）基因均发生功能丧失性突变。由于缺乏内源性的胸苷激酶，TK-1B 细胞无法利用核苷酸补救途径（Salvage pathway）将外源性的胸苷类似物磷酸化。这一纯合缺陷赋予了该细胞系对某些细胞毒性核苷类似物（如三氟胸苷 TFT，或5-溴脱氧尿苷 BUdr）的天然耐受性。这使其成为国际上用于开展哺乳动物细胞体外基因突变试验（MLA, Mouse Lymphoma Assay）、解析 DNA 修复缺陷以及评价新型抗癌核苷类药物代谢毒性的标准沙盘。

BioVector® TK-1B 技术与细胞学特征

1. 细胞形态与核心分子遗传学标记

• 显微形态表型 属于典型的悬浮生长细胞。镜下主要表现为大小相对均一、边缘清晰的圆形或卵圆形单细胞，在健康的对数生长期时倾向于保持独立的单细胞悬浮散在状态，极少出现大规模的自发聚集或形成紧密的细胞团。

• 生化与基因缺陷特征（核心学术亮点） 表型为 $TK1$ 纯合缺失/缺陷（$T{K}^{-/-}）$。

  • 筛选机制原理 在含有三氟胸苷（Trifluorothymidine, TFT）的选择性培养基中，正常的 TK+/+ 或 TK+/− 细胞会将 TFT 磷酸化并掺入 DNA，从而导致细胞死亡；而 BioVector® TK-1B 细胞则因 TK 缺失而无法利用 TFT，能够在含有 TFT 的高毒性背景下保持旺盛的克隆形成能力。

  • 可逆突变测定 该细胞可以配合小鼠淋巴瘤分析技术，用于检测外源理化因素是否能诱导其发生基因向后突变（Back mutation），从而恢复补救途径活力。

• 表面免疫表型分布 保留了成熟小鼠 T 淋巴细胞或 T 细胞淋巴瘤的特征性表面抗原标记，表现为 Thy-1.1 (CD90.1) 强阳性，部分亚株表现为 CD4 裂解阳性或 CD8 微弱表达，不表达 B 细胞经典表面标记（如 B200 或 CD19）。

2. 培养条件与操作指南

• 推荐基础培养基 优质的 BioVector® RPMI-1640 基础培养基或经改良的 Fischer's 培养基（占比 85 到 90 percent）。

• 推荐血清体系 10 到 15 percent 高质量且经过热灭活处理的 BioVector® Fetal Bovine Serum 胎牛血清（或根据特定 MLA 实验规范采用优质马血清 Horse Serum）。

• 常规细胞添加物 建议添加 1 mM 丙酮酸钠（Sodium Pyruvate）和 2 mM L-谷氨酰胺以维持最佳能量代谢。

• 培养环境参数 37 摄氏度，含有 5 percent 二氧化碳（CO2）的恒温恒湿培养箱。

• 倍增时间与维持丰度雷区 细胞增殖非常迅速，在对数生长期时的倍增时间通常仅为 12 到 18 小时 左右。

  • 起始接种密度 传代分瓶时的初始接种丰度推荐控制在 $1.0\times 10^5\text{cells/mL}$ 到 $2.0\times 10^5\text{cells/mL}$。

  • 维持窗口与分瓶 日常维持培养时，必须将细胞密度严格控制在 $1.0\times 10^5$ 至 $1.0\times 10^6\text{cells/mL}$ 之间。当细胞整体丰度接近或达到 $1.0\times 10^6\text{cells/mL}$ 时应立刻进行常规分瓶传代，否则细胞会因密度过高迅速步入衰亡期。

主要科研应用

1. 国际标准小鼠淋巴瘤基因突变试验（MLA）

• 环境与药物遗传毒性评价 BioVector® TK-1B 是经济合作与发展组织（OECD）化学品测试导则（如 OECD 490）所推荐的核心体外试验系统。科学家利用该细胞系的 TK 基因座变异，来精准定量和定性评估食品添加剂、农药、新药中间体等外源物质诱发哺乳动物细胞基因突变和染色体畸变（大菌落与小菌落分型）的能力。

2. 核苷类抗病毒/抗肿瘤药物的代谢屏障研究

• 补救途径靶向拦截 该细胞系被广泛用作负对照背景沙盘，用以筛选不依赖于内源性胸苷激酶-1（TK1）活化即可直接发挥 DNA 聚合酶抑制作用或链终止作用的新型抗癌、抗病毒前体药物。

技术指标简表

实验操作防坑指南由于 BioVector® TK-1B 细胞代谢极其旺盛且倍增极快，日常养护中千万不要使其过夜暴露在超过 $1.2\times 10^6\text{cells/mL}$ 的超饱和密度下。一旦发生过密过载，培养基会瞬间变黄酸化，细胞会产生大量的碎片并释放毒性凋亡因子，导致细胞活力断崖式下跌，且极难通过常规换液复苏。此外，在用于诱变剂 MLA 测试前，建议定期使用 THMG（胸腺嘧啶核苷、次黄嘌呤、甲氨蝶呤、甘氨酸）培养基进行“预清理”（Cleansing），以清除自发突变背景，确保后续药效和毒理数据的绝对灵敏与准确。

BioVector® TK-1B Mouse T-Cell Lymphoma Cell Line

General DefinitionBioVector® TK-1B is an immortalized mouse suspension cell line established from a spontaneous T-cell lymphoma in an AKR/J inbred mouse. Recognized globally as a gold-standard indicator model for testing gene mutations, DNA damage, and xenobiotic cytotoxicity, this cell line is curated across premier biological resource centers, including the German Collection of Microorganisms and Cell Cultures (DSMZ), the ATCC, and the European Collection of Authenticated Cell Cultures (ECACC). This technical specification file is structured under standardized repository identification parameters.

In molecular genetics and genetic toxicology, TK-1B occupies a highly foundational position. Its defining molecular trait is the homozygous deficiency/loss-of-function of the thymidine kinase-1 ($Tk1$ or $Tk$) locus, rendered via strategic chemical mutagenesis or targeted selection (TK−/− profile). Lacking an active endogenous salvage pathway machinery, TK-1B cells are entirely unable to phosphorylate exogenous thymidine analogs. This specific metabolic block endows the cells with a natural survival immunity against cytotoxic nucleoside derivatives like trifluorothymidine (TFT) or 5-bromo-2'-deoxyuridine (BUdr). Consequently, it serves as a prominent global assay vehicle for executing the mammalian in vitro Mouse Lymphoma Assay (MLA), mapping DNA repair pathway defects, and screening advanced nucleoside-based chemotherapeutic dynamics.

BioVector® TK-1B Technical & Cytological Specifications

1. Morphology and Core Molecular Genetic Signatures

• Microscopic Appearance Characterized as a strict suspension lineage. Under contrast phase examination, it presents as highly uniform, round-shaped single cells moving independently in suspension. Healthy log-phase cultures exhibit a low propensity for aggregate profiling or clump consolidation.

• Genotypic and Metabolic Deficiency (Academic Benchmark) Verified homozygous thymidine kinase deficiency ($T{K}^{-/-}$) status.

  • Selection Assay Mechanics While wild-type cells (TK+/+ or TK+/−) rapidly metabolize trifluorothymidine (TFT) and integrate the toxic compound into their genomic replication strands causing cell death, BioVector® TK-1B cells easily bypass TFT toxicity via salvage block, demonstrating robust cloning efficiency under high-dose nucleoside pressures.

  • Reversible Mutation沙盘 Serves as an exceptional analytical background to assess whether chemical mutagens can force backwards mutation rates that restore native salvage pathway kinase mechanics.

• Immunophenotypic Profile Retains diagnostic surface clusters native to mature murine T-lymphocytes, rendering strong positive signals for Thy-1.1 (CD90.1) while maintaining a strict negative matrix for B-cell markers such as B220 or CD19.

2. Cultivation & Subculturing Guidelines

• Recommended Basal Media Formulated using verified BioVector® RPMI-1640 basal medium or specialized Fischer's lymphoblast modification medium (85 to 90 percent).

• Serum Supplementation Augmented with 10 to 15 percent heat-inactivated BioVector® Fetal Bovine Serum (or high-grade Horse Serum customized to regulatory MLA validation frameworks).

• Culture Admixtures Enhanced with 1 mM Sodium Pyruvate and 2 mM L-Glutamine to optimize metabolic yield.

• Incubation Parameters 37 degrees Celsius in a humidified atmosphere charged with 5 percent Carbon Dioxide (CO2).

• Kinetics and Density Traps Proliferates aggressively under optimal conditions, demonstrating an unusually swift cell doubling time of approximately 12 to 18 hours.

  • Initial Seeding Boundary Always initiate or pass cultures within a range of $1.0\times 10^5\text{cells/mL}$ to $2.0\times 10^5\text{cells/mL}$.

  • Density Control Range Maintain the viable count strictly between $1.0\times 10^5$ and $1.0\times 10^6\text{cells/mL}$. Subculture immediately via dilution once the population approaches $1.0\times 10^6\text{cells/mL}$ to avert population-wide contact decay or nutrient-starvation crisis.

Primary Research Applications

1. Regulatory Mouse Lymphoma Assay (MLA) Frameworks

• Environmental and Pharmaceutical Genotoxicity Profiling BioVector® TK-1B serves as a cornerstone system conforming to global test guidelines, such as OECD Test Guideline 490. It enables precise quantification and phenotypic differentiation (large vs. small colony sizing) of forward mutation indices triggered by food matrices, chemical intermediates, or novel investigational drugs.

2. Metabolic Barrier Profiling of Nucleoside Therapeutics

• Salvage Bypass Diagnostics Deployed as an invaluable target platform to evaluate next-generation antiviral or anticancer pro-drugs, verifying if a compound can exert active chain termination or polymerase inhibition independent of host cell TK1 kinase activation.

Technical Data Summary

BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心

电话:400-800-2947

工作QQ/微信同号:1843439339

网址http://www.biovector.net